Analytical Data
-
Gene name
CRIPT
- Application
-
Alternative Names
CRIPT;Cysteine-rich PDZ-binding Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9P021
-
Expression Region
1-101aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMVCEKCE KKLGTVITPD TWKDGARNTT ESGGRKLNEN KALTSKKARF DPYGKNKFST CRICKSSVHQ PGSHYCQGCA YKKGICAMCG KKVLDTKNYK QTSV
-
Molecular Weight
14 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CRIPT (Cysteine-rich intestinal protein) is a cysteine-rich protein that has garnered attention in recent years due to its roles in various cellular processes. Initially discovered in the intestines, CRIPT is now recognized for its involvement in regulating cellular signaling, interactions with other proteins, and its potential roles in pathophysiological conditions such as cancer and inflammatory diseases. The study of CRIPT's structure and function is crucial for understanding its biological significance, particularly in the context of the gastrointestinal tract, where it may influence nutrient absorption and immune responses. Researchers are increasingly focused on CRIPT's potential as a biomarker for disease and as a therapeutic target, given its modulating effects on cellular pathways. The recombinant production of CRIPT allows for detailed biochemical and biophysical characterization, facilitating studies on its interactions with other molecules and providing insights into its functional mechanisms. Furthermore, understanding CRIPT's role in cellular homeostasis could lead to innovative approaches in treating diseases where CRIPT expression is altered. Overall, the ongoing research into CRIPT and its recombinant protein forms is paving the way for novel therapeutic strategies and enhancing our comprehension of critical biological processes.
